[Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts]
- PMID: 18396721
[Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts]
Abstract
Objective: To reduce restenosis in vein grafts after coronary artery bypass grafting, to investigate the effect of human tissue factor pathway inhibitor (TFPI) gene delivery on neointima formation.
Methods: The eukaryotic expressed plasmid vector pCMV-(Kozak) TFPI was constructed. Forty-eight Japanese white rabbits were randomly divided into 3 groups with 16 rabbits in each group: TFPI group, empty plasmid control group and empty control group. Animal model of common carotid artery bypass grafting was constructed. Before anastomosis, vein endotheliocytes were transfected with cationic liposome containing the plasmid pCMV-(Kozak) TFPI (400 microg) by pressurizing infusion (30 min) in TFPI group. In empty plasmid control group, vector pCMV-(Kozak) TFPI was replaced by empty plasmid pCMV (400 microg). In empty control group, those endotheliocytes were not interfered. After operation, vein grafts were harvested at 3 days for immunohistochemical, RT-PCR and Western-blot analyses of exogenous gene expression and at 30 days for histopathology measurement of intimal areas, media areas and calculation of intimal/media areas ratio. Luminal diameter and vessel wall thickness were also measured by vessel Doppler ultrasonography and cellular category of neointima was analyzed by transmission electron microscope at 30 days after operation.
Results: Human TFPI mRNA and protein were detected in TFPI group. The mean luminal diameter of the TFPI group, empty plasmid control group and empty control group was (2.68 +/- 0.32) mm, (2.41 +/- 0.23) mm and (2.38 +/- 0.21) mm respectively. There were statistically significant differences between TFPI group and control groups (P < 0.05). The vessel wall thickness of the TFPI group, empty plasmid control group and empty control group was (1.09 +/- 0.11) mm, (1.28 +/- 0.16) mm and (1.34 +/- 0.14) mm respectively. There were statistically significant differences between TFPI group and other control groups (P < 0.01). The mean intimal areas, the ratio of the intimal/media areas of the TFPI group were (0.62 +/- 0.05) mm2 and 0.51 +/- 0.08 respectively,whichwere reduced compared withthose of the two control groups (P < 0.05). The mean media areas had no significant differences among three groups (P > 0.05). Through transmission electron microscope analyses,no smooth muscle cells were seen in neointima of TFPI group in many visual fields,but smooth muscle cells were found in neointima of two control groups.
Conclusion: Human TFPI gene transfection reduced intimal thickness in vein grafts.
Similar articles
-
[Mechanism of intimal hyperplasia of venous grafts after coronary artery bypass grafting, an experimental study].Zhonghua Yi Xue Za Zhi. 2002 Nov 25;82(22):1550-2. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12609065 Chinese.
-
[Study on inhibiting the intimal hyperplasia after rabbit artery injury by local transfection of tissue-type plasminogen activator gene].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Mar;21(2):213-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005. PMID: 15766409 Chinese.
-
[Inhibition of intimal proliferation after vein grafting by chitosan nanoparticle with proliferation cell nuclear antigen-antisense oligo deoxy nucleotides].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Dec;21(12):1348-54. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007. PMID: 18277682 Chinese.
-
Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.Surgery. 1998 Feb;123(2):218-27. Surgery. 1998. PMID: 9481409 Review.
-
Therapeutics of vein graft intimal hyperplasia: 100 years on.Ann Thorac Surg. 2007 Jul;84(1):317-23. doi: 10.1016/j.athoracsur.2007.02.035. Ann Thorac Surg. 2007. PMID: 17588453 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous